Medicare Enrolled

Dr. James Mason, MD

Optician · Waco, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
405 LONDONDERRY, Waco, TX 76712
2547729004
In practice since 2005 (20 years)
NPI: 1699763375 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mason from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mason? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mason

Dr. James Mason is an optician in Waco, TX, with 20 years in practice. Based on federal Medicare data, Dr. Mason performed 4,105 Medicare services across 1,994 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mason received a total of $1,470 from 20 pharmaceutical and/or device companies across 94 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mason is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 16% volume in TX$ $1,470 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,105
Medicare services
Top 16% in TX for optician
1,994
Unique beneficiaries
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~205 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Destruction of precancerous skin growths, 2-142,303$5$20
Destruction of precancerous skin growth, 1600$42$196
Office visit, established patient (10-19 min)343$36$164
Office visit, established patient (20-29 min)339$56$263
Destruction of skin growths (warts/lesions), 1-14174$73$331
New patient office visit (30-44 min)147$66$326
New patient office or other outpatient visit, 15-29 minutes92$45$211
Skin biopsy, tangential49$66$296
Destruction of precancer skin growth, 15 or more growths47$118$493
Simple or single drainage of skin abscess11$98$367
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,470
Total received (2018-2024)
Avg $210/year across 7 years
Top 48% in TX for optician
20
Companies
94
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,470 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$460
2023
$337
2022
$199
2021
$35
2020
$145
2019
$49
2018
$244

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$343
Novartis Pharmaceuticals Corporation
$145
Celgene Corporation
$137
E.R. Squibb & Sons, L.L.C.
$103
Boehringer Ingelheim Pharmaceuticals, Inc.
$85
UCB, Inc.
$74
LEO Pharma Inc.
$69
Biofrontera Inc.
$68
AbbVie, Inc.
$68
Arcutis Biotherapeutics, Inc.
$67
SUN PHARMACEUTICAL INDUSTRIES INC.
$61
Sun Pharmaceutical Industries Inc.
$55
PFIZER INC.
$42
ABBVIE INC.
$29
Lilly USA, LLC
$27
Regeneron Healthcare Solutions, Inc.
$27
DUSA Pharmaceuticals, Inc.
$21
DERMIRA, INC.
$19
Galderma Laboratories, L.P.
$15
Mylan Pharmaceuticals Inc.
$14
Top 3 companies account for 42.5% of total payments
Associated products mentioned in payments ›
ABSORICA LD · ADBRY · AMELUZ · BLU-U · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · Bimzelx · COSENTYX · CYLTEZO · Cimzia · EUCRISA · Humira · LIBTAYO · ORACEA · Olux · Otezla · QBREXZA · RINVOQ · SPEVIGO · Sotyktu · TALTZ · VERZENIO · Winlevi · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $36 per 100 Medicare services performed
Looking for a optician in Waco?
Compare opticians in the Waco area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
31
Per 100K population
11.8
County median income
$63,888
Nearest hospital
ASCENSION PROVIDENCE
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Mason is a clinical cardiology specialist, with above-average Medicare volume (top 16% in TX), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Mason experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Mason performed 2,303 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mason receive payments from pharmaceutical companies?
Yes. Dr. Mason received a total of $1,470 from 20 companies across 94 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mason's costs compare to other opticians in Waco?
Dr. Mason's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mason) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →